Our Team

M. Javad Aman, PhD

M. Javad Aman, PhD

PRESIDENT AND CSO

Javad leads IBT and its innovative science programs. He is a distinguished researcher in viral and bacterial diseases with 75+ publications.

Robin Douglas

Robin Douglas

VP, Programs & Operations

Robin leads IBT Bioservices with its state-of-the-art infectious disease research capabilities and strong customer service focus.

Rick Holtsberg, PhD

Rick Holtsberg, PhD

VP, Manufacturing & Bioanalytics

Rick leads IBT Bioservices' assay & protein services group and develops IBT's biochemical reagent portfolio. See Rick's publications.

Rajan Adhikari, PhD

Rajan Adhikari, PhD

Assistant Director, Bacteriology

Rajan investigates bacterial pathogens and leads antibacterial vaccine and therapeutic development programs. See Rajan's publications.

Haiyan Olekszak, PhD, MBA, PMP

Haiyan Olekszak, PhD, MBA, PMP

Asst. Director, in vitro Bioservices

Dr. Olekszak joined IBT in 2017 and leads the highly productive in vitro bioservices team. See Dr. Olekszak’s publications.

Agnes Chenine, PhD

Agnes Chenine, PhD

Assistant Director, Antiviral Research

Agnes oversees the in vivo studies program for testing new therapies and vaccines in various rodent models. See Agnes’s publications.

Hatice Karauzum, PhD

Hatice Karauzum, PhD

Assistant Director, Immunology

Hati investigates bacterial pathogenesis and cellular immune responses. See Hati’s publications.

 

 

Haimi Shiferaw

Haimi Shiferaw

Business Development Advisor

Haimi leads IBT Bioservices strategic growth, marketing, and customer management team.

Thomas Kort

Thomas Kort

Tom works on protein expression and custom scientific projects. See Tom’s publications.

Sergey Shulenin, PhD

Sergey Shulenin, PhD

Sergey works on assay development and protein expression. See Sergey's publications.